account_id none on file
legal_name Artelo Biosciences, Inc.
ticker ARTL
cik 1621221
domain artelobio.com
linkedin_company_url https://www.linkedin.com/company/artelo-biosciences-inc
entry_point_account_id none on file
name Artelo Biosciences Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 4 executives 1 family 0
why_nownone on file
callsnone on file
filings
On May 12, 2021, the Company entered into a lease arrangement for office space in the U.S. On March 6, 2024, the Company entered into an amended agreement with the landlord to extend the lease commencing in September 2024, and effective until August 2027.
filing / Aug 12, 2026 / receipt
Mark Spring was appointed chief financial officer, treasurer, principal financial officer and principal accounting officer in November 2025.
filing / Jun 5, 2026 / receipt
Spring joined us as Chief Financial Officer and Treasurer effective November 1, 2025. (2) In accordance with SEC rules, the amounts shown reflect the aggregate grant date fair value of stock awards granted to Non-Employee Directors during the applicable year, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (“FASB ASC 718”).
filing / Jun 5, 2026 / receipt
We are embracing technology to provide expanded access, improved communication, reduced environmental impact and cost savings for our stockholders and the Company.
filing / Jun 5, 2026 / receipt
executives
| Mark Spring | Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-11 | earnings call | scheduled | ir |
changes
mcp_package_hint
slug artelo-biosciences-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$